Back to results
UnknownPhase 2

Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease

NCT05578443

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fujian Medical University Union Hospital

Fuzhou, Fujian, China

Contact

Xiaodong Pan

86218341pxd77316@163.com
View on ClinicalTrials.gov
Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease — TrialFind